Moderna Inc (MRNA)
122.17
+1.77
(+1.47%)
USD |
NASDAQ |
Jul 26, 16:00
121.50
-0.67
(-0.55%)
After-Hours: 20:00
Moderna Gross Profit Margin (Quarterly): 42.52% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 42.52% |
December 31, 2023 | 66.97% |
September 30, 2023 | -25.41% |
June 30, 2023 | -131.3% |
March 31, 2023 | 56.91% |
December 31, 2022 | 62.75% |
September 30, 2022 | 65.84% |
Date | Value |
---|---|
June 30, 2022 | 69.75% |
March 31, 2022 | 82.88% |
December 31, 2021 | 86.30% |
September 30, 2021 | 85.05% |
June 30, 2021 | 82.21% |
March 31, 2021 | 88.93% |
December 31, 2020 | 96.51% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-131.3%
Minimum
Jun 2023
96.51%
Maximum
Dec 2020
52.13%
Average
68.36%
Median
Gross Profit Margin (Quarterly) Benchmarks
Merck & Co Inc | 77.56% |
Pfizer Inc | 77.29% |
Eli Lilly and Co | 80.91% |
Novavax Inc | 36.91% |
Johnson & Johnson | 69.40% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -39.30% |
Return on Assets | -29.66% |
Return on Invested Capital | -39.30% |
Profit Margin (Quarterly) | -703.6% |
Operating Margin (Quarterly) | -758.1% |
Return on Net Operating Assets | -123.5% |